Integrated DNA Technologies receives licence for MGB Eclipse Probes

Integrated DNA Technologies has acquired a license from ELITech to manufacture and supply MGB Eclipse Probes.

To be sold for use as a component in human in vitro diagnostic tests, the products are a widely used type of quantitative real-time polymerase chain reaction (qPCR) probe, comprised of oligonucleotides coupled to fluorescent dyes, Eclipse Dark Quenchers and the Minor Groove Binder (MGB).

The company can leverage its expertise in oligonucleotide and GMP manufacturing to offer these probes, ensuring diagnostic test providers can now benefit from the high quality, reliable delivery times, competitive pricing and excellent customer service for which it is known.

Roman Terrill, the firm's general counsel and GMP business unit leader, said: "Many of our customers have developed qPCR-based diagnostic tests using MGB Eclipse Probes labeled for research use only. Integrated DNA Technologies can now help them offer GMP-manufactured, cost-effective probes for laboratory developed tests."

Integrated DNA Technologies was founded in 1987 and serves the needs of 80,000 life sciences researchers worldwide.